Krystal Biotech Inc (NASDAQ:KRYS)
| 106.90 Delayed Data As of 3:59pm ET |  +3.50 / +3.38%Today’s Change | 69.81 Today|||52-Week Range 132.68 | +34.94% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | 2.0K | 23.0K | 141.0K | -- | ||
| Operating Expenses | Gross Income | -2.0K | -23.0K | -141.0K | -- | |
| General Expenses | 1.1M | 4.7M | 11.8M | -- | ||
| Research And Development | 741.0K | 3.2M | 7.8M | -- | ||
| Total Operating Expenses | 1.1M | 4.8M | 11.9M | -- | ||
| Non-Operating Expenses | Operating Income | -1.1M | -4.8M | -11.9M | -- | |
| Interest Expense On Debt | 7.0K | 3.3M | 0.00 | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -1.2M | -7.9M | -10.9M | -- | |
| Net Income | -1.2M | -7.9M | -10.9M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 10.2M | 5.4M | 11.2M | -- | |
| Shares To Calculate EPS Diluted | 10.2M | 5.4M | 11.2M | -- | ||
| Earnings Per Share | EPS | -$0.11 | -$1.48 | -$0.97 | -- | |
| EPS Diluted | -$0.11 | -$1.48 | -$0.97 | -- | ||
